| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Chemistry | 207 | 290 | 450 | 34 |
| Medicine | 1118 | 108 | 148 | 21 |
The scientific interests tackled in the journal are Pharmacology, In vivo, Drug delivery, Biochemistry and Biophysics. The work on Pharmacology tackled in Molecular Pharmaceutics brings together disciplines like Cytotoxicity and Doxorubicin. Molecular Pharmaceutics explores topics in In vivo which can be helpful for research in disciplines like Molecular biology, Cancer research and In vitro.
The research on Molecular biology featured in the journal combines topics in other fields like Cell culture, Transfection, Gene delivery and Cell biology. Some problems in Cancer research that were presented in it overlapped with concepts under Cancer cell and Cancer. The study of Drug delivery, which falls within the realm of Nanotechnology, was the main focus of the presentations.
The main emphasis of Molecular Pharmaceutics is the subject of Biochemistry, focusing on Peptide. The Biophysics study tackled is a key component of adjacent topics in the area of Nanoparticle.
The most cited articles focus largely on the fields of Pharmacology, In vivo, Drug delivery, Biochemistry and Biophysics. In addition to Pharmacology research, the published articles aim to explore topics under Paclitaxel and Doxorubicin. The published papers facilitate discussions on In vivo that incorporate concepts from other fields like Cancer cell, Molecular biology, Cancer research and In vitro.
The primary areas of discussion in the journal are In vivo, Cancer research, Drug delivery, Pharmacology and Biophysics. Topics in In vivo explored in it were investigated in conjunction with research in Pharmacokinetics, In vitro, Doxorubicin and Cell biology. Issues in Cancer research were discussed, taking into consideration concepts from other disciplines like Cancer cell, Cancer, Breast cancer and Apoptosis.
Nanocarriers is a major topic of Drug delivery research. Drug is a focus of the Pharmacology works in it. It dives deep in exploring the relationship between the study of Biophysics and Nanoparticle.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Molecular Pharmaceutics (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Molecular Pharmaceutics (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 5.80% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 15.08% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.69% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 16.62% of all publications and 60.62% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
Takashi Nakamura;Minori Kawai;Yusuke Sato;Masatoshi Maeki
(2020)Satoshi Uchida;Federico Perche;Chantal Pichon;Chantal Pichon;Horacio Cabral
(2020)Harkiranpreet Kaur Dhaliwal;Yingfang Fan;Jonghan Kim;Mansoor M Amiji
(2020)Despo Chatzikleanthous;Derek T O'Hagan;Roberto Adamo
(2021)Sugandha Saboo;Umesh S Kestur;Daniel P Flaherty;Lynne S Taylor
(2020)Li Zhang;Shili Yang;Ling Rong Wong;Hui Xie
(2020)Tze Ning Hiew;Dmitry Y Zemlyanov;Lynne S Taylor
(2021)Abdul Basit;Naveen K. Neradugomma;Christopher Wolford;Peter W. Fan
(2020)For those interested in pursuing a medical career beyond traditional medicine, several related online degrees and training programs offer flexible options. Programs like rn to bsn no practicum enable registered nurses to advance their education without onsite clinical requirements, making it easier to balance work and study.
Advanced practice nurses seeking to elevate their expertise can explore the shortest dnp programs online, which provide efficient pathways to earn a Doctor of Nursing Practice degree through online coursework. For those looking for a less intensive route, options like the easiest dnp program offer streamlined curricula without compromising quality.
Additionally, individuals interested in starting their healthcare careers quickly might consider a medical assistant training program, many of which can be completed in just a few weeks. These accelerated programs prepare students for clinical and administrative tasks essential in medical settings, offering a fast track to employment.
Overall, these diverse online pathways complement traditional medical education by providing accessible and adaptable options for career growth in the healthcare field.
